Welcome to our dedicated page for Viracta Therapeutics SEC filings (Ticker: VIRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
viracta is focused on advancing a proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus, and will pursue opportunities to address other serious virus-associated disease.Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
What is the current stock price of Viracta Therapeutics (VIRX)?
The current stock price of Viracta Therapeutics (VIRX) is $0.00978 as of July 16, 2025.
What is the market cap of Viracta Therapeutics (VIRX)?
The market cap of Viracta Therapeutics (VIRX) is approximately 6.0M.
Viracta Therapeutics Inc
OTC:VIRX
VIRX Rankings
VIRX Stock Data
6.02M
38.65M
2.99%
21.18%
0.62%
Biotechnology
Pharmaceutical Preparations
United States
CARDIFF